Back to search

Aristotle University Of Thessaloniki (AUTH)

Πειραματική μελέτη της δράσης του εκχυλίσματος του φυτού Crocus Sativus Linneaus σε κακοήθη γλοιώματα του εγκεφάλου

Abstract

dc:description

Gliomas are the most common malignant tumours of the brain and glioblastoma multiforme (GBM) is the most frequent over the age of 55 years of old. The median survival of GBM patients is 9-15 months, while the overall 5-year survival is approximately 5,6%. The 5-year survival in the group below the age of 20 years is as low as 16,6%. In this research project, the crude extract of Crocus Sativus Linneaus has been tested for its anti-cancerous activity in C6 glioma cell line and secondly for its potential as an anticancer agent when administered in an orthotopic rat glioma model via the technique of convection enhanced delivery (CED). Primary targets: 1) in vitro confirmation of the anti-cancerous activity of crude extract of Crocus Sativus Linneaus against C6 glioma cell line, 2) the investigation of its anti-cancerous activity in an in vivo rat glioma model via the technique of CED. Secondary targets: 1) the in vitro titration of Crocus Sativus Linneaus as an antineoplastic agent for glioma, 2) the investigation of the mechanism of action of Crocus Sativus Linneaus crude extract, 3) the combinational study of the Crocus Sativus Linneaus crude extract and the approved chemotherapeutic agent temozolomide (TMZ), 4) the establishment of an orthotopic rat glioma model with C6 cell line, and 5) the application of convection enhanced delivery in an in vivo rat glioma model. Our study demonstrated that Crocus Sativus Linneaus crude extract inhibits in vitro C6 cell proliferation and exhibits synergistic action with temozolomide, achieving the same results in C6 cells with a reduced TMZ dose in their combination. CSL causes a non-apoptotic calpain dependent death in C6 rat glioma cells, combined possibly with autophagy. Although the in vivo glioma C6 model was developed both subcutaneously and orthotopically in SCID BALB/c mice, it was not developed orthotopically in Wistar rats. Finally, the CED technique of the macro-molecular Crocus Sativus Linneaus crude extract has been successfully applied without perioperative complications. We conclude that Crocus Sativus L. crude extract can reduce cell viability of the C6 glioma cell line. The combination of the extract with the alkylating agent temozolomide can improve the antineoplastic effect even with lower dose of temozolomide. C6 cell death was induced by a non-apoptotic calpain-dependent death. The immunogenicity of C6 glioma cell line in an orthotopic in vivo glioma model in Wistar rats was confirmed according to a few studies in the literature, whereas the C6 glioma model was developed successfully in immunocompromised mice. The administration of macromolecular substances with the help of CED is safe, does not present major technical difficulties, and achieves sufficient concentric intraparenchymal infiltration around the catheter. CED offers a new route of administration of macromolecules in the brain bypassing the blood-brain-barrier and limiting systematic adverse effects.

Degree

thesis:*
Grantor dc:publisher
Aristotle University Of Thessaloniki (AUTH)
Year dc:date
2019

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Giakoumettis, Dimitrios
  • Γιακουμεττής, Δημήτριος

Subjects

dc:subject × 14

Rights

dc:rights
Statement dc:rights
  • BY_NC_ND
Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/45945

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Giakoumettis, Dimitrios; Γιακουμεττής, Δημήτριος. Πειραματική μελέτη της δράσης του εκχυλίσματος του φυτού Crocus Sativus Linneaus σε κακοήθη γλοιώματα του εγκεφάλου. Aristotle University Of Thessaloniki (AUTH), 2019. http://hdl.handle.net/10442/hedi/45945